ADDvise receives order worth approximately MSEK 6 - Regulatory information

ADDvise Group AB (publ) subsidiary Hettich Labinstrument Aktiebolag has received an order from the Swedish Defence Materiel Administration on behalf of the National Board of Health and Welfare worth approximately MSEK 6 regarding medical swabs. The medical swabs will, among other things, be used for sample-taking of patients tested for suspected COVID-19 infection. Delivery is planned to take place during the second quarter 2020. 

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 21 April 2020 at 10:50 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.